View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
December 10, 2020

Addenbrooke’s Hospital to use Microsoft AI for cancer treatment

Microsoft has announced that Addenbrooke’s Hospital in Cambridge is set to use its InnerEye artificial intelligence (AI) technology for cancer treatment.

Microsoft has announced that Addenbrooke’s Hospital in Cambridge is set to use its InnerEye artificial intelligence (AI) technology for cancer treatment.

Free Whitepaper
img

How is AI impacting the future of Healthcare?

The applications of AI in healthcare are many, with the potential to transform key aspects of the industry and drive innovation. Uses include data management, remote surgery, diagnostic and procedural AI assistants, drug discovery, and clinical trial design. GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019.

GlobalData’s AI in Healthcare Thematic Research report provides you with an in-depth lens into the impact of artificial intelligence on the industry. We highlight both the challenges and opportunities associated with the innovative technology now, and in the future. Our report also covers:

  • Major players and companies
  • Market size and growth forecasts
  • Case studies
  • Sector scorecard

According to our recent survey, almost two-thirds of pharma professionals expect AI to be the leading disruptive technology in the pharma sector over the next two years. With threats to the industry exacerbated by the COVID-19 pandemic, you should be proactive in adapting strategies and processes to help you remain competitive. Download the full report to get ahead of the competition.

by GlobalData
Enter your details here to receive your free Whitepaper.

The use of InnerEye makes the hospital the first in the world to use the technology to accelerate cancer treatment and boost survival rates.

Microsoft’s Cambridge Research Lab developed the InnerEye project, which will be used to develop AI models.

These models will be created by leveraging the data of the hospital and point out healthy organs and tumours on patient scans automatically.

A clinical oncologist will check and confirm the scans, following which the patient will be treated.

This method is expected to reduce the treatment planning stage, which is key for cancers that occur in the head and neck. These cancers grow fast when not treated.

It will also help increase the survival rates, claim experts.

Addenbrooke’s oncologist and InnerEye co-lead Dr Raj Jena said: “The results from InnerEye are a game-changer.

“To be diagnosed with a tumour of any kind is an incredibly traumatic experience for patients.

“So as clinicians we want to start radiotherapy promptly to improve survival rates and reduce anxiety.

“Using machine learning tools can save time for busy clinicians and help get our patients into treatment as quickly as possible.”

Data states that around half of the population in the UK, at some point in their lives, will be diagnosed with cancer.

The hospital has worked with Microsoft since the past eight years for the development and piloting of InnerEye.

This is said to be the first instance where an NHS trust has used deep-learning solution focussed on its own data.

Related Companies

Free Whitepaper
img

How is AI impacting the future of Healthcare?

The applications of AI in healthcare are many, with the potential to transform key aspects of the industry and drive innovation. Uses include data management, remote surgery, diagnostic and procedural AI assistants, drug discovery, and clinical trial design. GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019.

GlobalData’s AI in Healthcare Thematic Research report provides you with an in-depth lens into the impact of artificial intelligence on the industry. We highlight both the challenges and opportunities associated with the innovative technology now, and in the future. Our report also covers:

  • Major players and companies
  • Market size and growth forecasts
  • Case studies
  • Sector scorecard

According to our recent survey, almost two-thirds of pharma professionals expect AI to be the leading disruptive technology in the pharma sector over the next two years. With threats to the industry exacerbated by the COVID-19 pandemic, you should be proactive in adapting strategies and processes to help you remain competitive. Download the full report to get ahead of the competition.

by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Get important industry news and analysis sent to your inbox
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Hospital Management